- Home
- LEA vs AXSM Comparison
LEA vs AXSM Comparison
Compare LEA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEA
- AXSM
- Stock Information
- Founded
- LEA 1917
- AXSM 2012
- Country
- LEA United States
- AXSM United States
- Employees
- LEA N/A
- AXSM N/A
- Industry
- LEA Auto Parts:O.E.M.
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- LEA Consumer Discretionary
- AXSM Health Care
- Exchange
- LEA Nasdaq
- AXSM Nasdaq
- Market Cap
- LEA 5.3B
- AXSM 5.1B
- IPO Year
- LEA N/A
- AXSM 2015
- Fundamental
- Price
- LEA $94.74
- AXSM $107.35
- Analyst Decision
- LEA Buy
- AXSM Strong Buy
- Analyst Count
- LEA 12
- AXSM 15
- Target Price
- LEA $115.42
- AXSM $170.20
- AVG Volume (30 Days)
- LEA 593.2K
- AXSM 647.1K
- Earning Date
- LEA 05-06-2025
- AXSM 05-05-2025
- Dividend Yield
- LEA 3.28%
- AXSM N/A
- EPS Growth
- LEA N/A
- AXSM N/A
- EPS
- LEA 8.59
- AXSM N/A
- Revenue
- LEA $22,871,700,000.00
- AXSM $432,157,000.00
- Revenue This Year
- LEA N/A
- AXSM $62.62
- Revenue Next Year
- LEA $3.70
- AXSM $62.94
- P/E Ratio
- LEA $10.93
- AXSM N/A
- Revenue Growth
- LEA N/A
- AXSM 72.16
- 52 Week Low
- LEA $73.85
- AXSM $64.11
- 52 Week High
- LEA $133.56
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- LEA 64.33
- AXSM 47.75
- Support Level
- LEA $92.72
- AXSM $103.02
- Resistance Level
- LEA $97.88
- AXSM $110.95
- Average True Range (ATR)
- LEA 2.62
- AXSM 3.97
- MACD
- LEA 1.17
- AXSM -0.13
- Stochastic Oscillator
- LEA 79.07
- AXSM 26.44
About LEA Lear Corporation
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns most of its revenue from the seating segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.